16 Pages Posted: 17 Jun 2006
On innovation grounds, pharmaceutical patents are unnecessary in low income populations, since such markets cannot do much to support global pharmaceutical profits. The public health needs of low income populations require patented drugs to be manufactured at the marginal cost of production, without R&D cost recovery. Nonrivalrous access to pharmaceutical knowledge achieves both goals simultaneously.
Keywords: pharmaceutical, pricing, patents, innovation, nonrivalrous, access, developing countries, low income countries
JEL Classification: H41, H51, I18, K11, K19, K32, K33
Suggested Citation: Suggested Citation
Outterson, Kevin, Fair Followers: Expanding Access to Generic Pharmaceuticals for Low- and Middle-Income Populations. THE POWER OF PILLS, Jillian Clare Cohen, Patricia Illingworth, Udo Schuklenk, eds., University of Michigan Press, 2005. Available at SSRN: https://ssrn.com/abstract=908586 or http://dx.doi.org/10.2139/ssrn.667323